| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.079 | 0.3 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |